U
AMBI

UBS’s Ambit Biosciences Corp AMBI Stock Holding History

UBS’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.85M Buy
+184,991
New +$1.27M ﹤0.01% 2579
2014
Q2 		– Sell
-27,776
Closed -$253K – 11269
2014
Q1 		$253K Buy
27,776
+27,016
+3,555% +$287K ﹤0.01% 4953
2013
Q4 		$7K Buy
760
+408
+116% +$5.45K ﹤0.01% 9387
2013
Q3 		$5K Buy
+352
New +$4.67K ﹤0.01% 9503

Other funds holding AMBI

FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UBS's AMBI Position: Q3 2014 in Review

UBS opened a new position in Ambit Biosciences Corp (AMBI) in Q3 2014: 184,991 shares worth $2.85M. The stake represents ﹤0.01% of the portfolio and ranks #2579 among its holdings. This is a return to the name: UBS previously reported a position in AMBI as recently as Q1 2014.

UBS first reported a position in AMBI in Q3 2013 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold AMBI as of Q3 2014.

  • UBS held 184,991 shares of Ambit Biosciences Corp worth $2.85M as of Q3 2014.
  • Ambit Biosciences Corp was a new UBS position in Q3 2014.
  • Ambit Biosciences Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2579 holding.
  • UBS first reported a position in Ambit Biosciences Corp in Q3 2013 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.